Sickle Cell Patients to Get Better Treatment After £9m Boost (UK Department of Health & Social Care)

Sickle cell patients to get better treatment after £9m boost (UK Department of Health & Social Care)

) Patients with sickle cell disease are set to benefit from quicker and more accessible treatment thanks to major upgrades to life saving technology. Backed by a £9million investment from NHS England, the government is set to transform apheresis services - a specialised set of treatments which remove harmful components from a patient's blood - by funding more specialist treatment centres, as well as expanding access to cutting-edge technology. F…

Sickle cell patients to have quicker and more accessible treatment in England nearly one year after Scotland

Professor John Robertson OBA In the Guardian today, the above and: People living with sickle cell disease in England are to benefit from quicker and more accessible treatment due to a £9m investment, the government has announced. Apheresis services, which are a type of treatment that removes harmful components from a patient’s blood, are to improve across England through the funding of more specialist treatment centres. The funding will ensure t…

Sickle cell patients to get better treatment after £9m boost

Patients living with rare blood disorders to benefit from increased access to treatment and availability of services, thanks to £9 million investment.

VAS-101 (Vasceptor) Receives Orphan Drug Designation for Sickle Cell Disease

An ongoing phase 1 study aims to prove the safety and tolerability of VAS-101, as well as its effect on blood flow dynamics, red blood cell sickling, and oxygen dissociation.